A Phase II Study of Sorafenib in Malignant Mesothelioma: Results of Cancer and Leukemia Group B 30307

Title
A Phase II Study of Sorafenib in Malignant Mesothelioma: Results of Cancer and Leukemia Group B 30307
Authors
Keywords
-
Journal
Journal of Thoracic Oncology
Volume 5, Issue 10, Pages 1655-1661
Publisher
Elsevier BV
Online
2010-08-25
DOI
10.1097/jto.0b013e3181ec18db

Ask authors/readers for more resources

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now